Summary
In a Swiss multicenter study, a significant increase of HLA-DR4 was found in patients with rheumatoid arthritis when compared with normal controls (P<0.01). This increase was limited to patients with rheumatoid factors; it was strongest in patients with high titers. Similarly, the frequency of HLA-DR4 was higher in patients with larger amounts of circulating immune complexes when compared with patients with low amounts. No correlation with the presence of antinuclear antibodies was found. HLA-DR1 was more frequent in patients with rheumatoid arthritis than in controls (N.S.). This was due to an increase of HLA-DR1 in patients without rheumatoid factors (P<0.05), low amounts of circulating immune complexes (N.S.) and without antinuclear antibodies (P<0.05).
Similar content being viewed by others
References
Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298:869–871
Panayi GS, Wooley P, Batchelor JR (1978) Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 2:1326–1328
Thomsen M, Morling N, Snorrason E, Svejgaard A, Sørensen SF (1979) HL-Dw4 and rheumatoid arthritis. Tissue Antigens 13:56–60
Scherak O, Smolen JS, Mayr WR (1980) Rheumatoid arthritis and B-lymphocyte alloantigen HLA-DRw4. J Rheumatol 7:9–12
Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ (1980) HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-Penicillamine in patients with rheumatoid arthritis. N Engl J Med 303:300–302
Ropes MW, Bennet GA, Cobb S, Jacox R, Jessar RA (1958) 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176
Werner-Favre C, Klouda PT, Corréa MC, Vassali P, Jeannet M (1977) Isolation of B and T-lymphocytes by nylon fiber columns. Tissue Antigens 9:227–229
Bodmer WF, Batchelor JR, Bodmer JG, Festenstein H, Morris JP (1978) Histocompatibility testing 1977. Munksgaard, Copenhagen
Rheims MS, McCoy FW, Burrell RG, Buehler FV (1957) Modification of latex-fixation test for study of RA. J Lab Clin Med 50:113–118
Zubler RH, Nydegger U, Perrin LH, Fehr K, McCormick J, Lambert PH, Miescher PA (1976) Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125l-C1q binding activity with clinical and biological features of the disease. J Clin Invest 57:1308–1319
Fallet M, Celada A, Cruchaud A (1981) Evaluation de deux méthodes de détection des anticorps anti-ADN natifs dans les maladies du collagène. Schweiz Med Wochenschr 111:488–494
Woolf B (1955) On estimating the relation between blood group and diseases. Ann Hum Genet 19:251–253
Svejgaard A, Jersild C, Staub Nielsen L, Bodmer WF (1974) HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens 4:95–105
Dobloug JA, Førre O, Kaess E, Thorsby E (1980) HLA antigens and rheumatoid arthritis. Arthritis Rheum 23:309–313
Stastny P (1980) Rheumatoid arthritis. In: Terasaki PJ (ed), Histocompatibility testing 1980. Munksgaard, Copenhagen, pp 681–686
Karr RW, Rodey GE, Lee T, Schwartz BD (1980) Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum 23:1241–1245
Nichol FE, Woodrow JC (1981) HLA-DR antigens in indian patients with rheumatoid arthritis. Lancet I:220–221
Author information
Consortia
Additional information
Participants: T. L. Vischer (coordination and correspondence), Division of Rheumatology, Hôpital Cantonal, CH-1211 Genève 4;
M. Jeannet and V. von Fliedner (HLA-antigen determinations), Transplantation Immunology Unit, Division of Immunology; A. Cruchaud (antinuclear antibodies), Division of Immunology; A. Micheli (rheumatoid factors), Division of Rheumatology; N. Carpentier and P.H. Lambert (C1q-binding tests), WHO Immunology Research and Training Laboratory; all from the Department of Medicine, University of Geneva. P. Vuagnat (statistics), Department of Mathematics, University of Geneva
Centers: Basel: U. Steiger (Medizinische Universitätsklinik); Bern: N. Gerber (Universitäts-Rheumaklinik); Fribourg: I. Radi (Hôpital Cantonal); Genève: T. L. Vischer (Hôpital Cantonal); La Chaux-de-Fonds: H. Ott (Service de Physiatrie, Hôpital de la Chaux-de-Fonds); Lausanne: T. Bitter and J. C. Gerster (Service de Physiatrie, CHUV);
Leukerbad: N. Fellmann (Rheumaklinik); Valens: B. Stojan (Klinik Valens); Winterthur: H. Hunziker (Kantonsspital); Zürich: M. Baumgartner (Klinik Wilhelm Schulthess), D. Gross and M. Lamoth (Triemlispital), K. Fehr and M. Felder (Universitäts-Rheumaklinik); Zurzach: W. Kunz (Rheumaklinik)
Rights and permissions
About this article
Cite this article
Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research. HLA-DR antigens in rheumatoid arthritis. Rheumatol Int 1, 111–113 (1981). https://doi.org/10.1007/BF00541254
Issue Date:
DOI: https://doi.org/10.1007/BF00541254